• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Potential antitumor agents. 29. Quantitative structure-activity relationships for the antileukemic bisquaternary ammonium heterocycles.

作者信息

Denny W A, Atwell G J, Baguley B C, Cain B F

出版信息

J Med Chem. 1979 Feb;22(2):134-50. doi: 10.1021/jm00188a005.

DOI:10.1021/jm00188a005
PMID:423193
Abstract

Quantitative relationships between physicochemical drug properties and antileukemic (L1210) efficacy have been examined for a series of bisquaternary ammonium heterocycles employing multiple variable regression analysis. Three measures of biologic response were examined: ILSmax, the percentage increase in mean life span of leukemic animals at the LD10 dose; D40, the drug dose necessary to provide 40% increase in life span; and CI (=LD 10/D40), the chemotherapeutic index. A cross correlation matrix between these three measures and the LD10 values demonstrates ILSmax and CI to be independent of toxicity. D40 is highly inversely correlated with LD10 and positively correlated with ILSmax, suggesting that this parameter measures a composite of both drug selectivity and toxicity. Superior regression equations resulted at all stages employing ILSmax as a measure of antitumor selectivity. Acceptable equations modeling LD10 could not be obtained. There was a parabolic relationship between agent lipophilic-hydrophilic balance, measured as chromatographic Rm values, and ILSmax. To reduce residual variance in the L1210 screening data, not accepted by this parabolic equation, measures of agent-DNA interaction were investigated as possible indices of site fit. Relative levels of drug-DNA interaction were obtained by spectrofluorimetric quantitation of drug displacement of DNA-bound ethidium. Addition to regression equations of agent C50 values for calf thymus DNA, those micromolar drug concentrations necessary to displace 50% of the ethidium bound to that DNA, provided a significant reduction in the screening data variance. C50 values for drug interactions with poly[d(A-T)] and poly[d(G-C)] were also investigated as possible indicators of drug selectivity towards different DNA sites. Marked differences were observed in the C50 values for the two synthetic nucleic acids, with those for calf thymus DNA and poly[d(G-C)] proving highly covariant. A regression equation containing a positive term in C50[poly[d(G-C)]] and a negative term in C50-[poly[d(A-T)]] provided the greatest acceptance of the variation in the biologic data. The term in C50[poly[d(A-T)]] is the single most important equation term, alone accounting for 35% of the variance in the data. This best equation provides both an adequate summary of the L1210 screening data for the 174 active compounds considered and a physical explanation for the antitumor selectivity for these agents. The major factor influencing antitumor selectivity in these drugs is their ability to distinguish alternating adenine-thymine sequences in DNA.

摘要

相似文献

1
Potential antitumor agents. 29. Quantitative structure-activity relationships for the antileukemic bisquaternary ammonium heterocycles.
J Med Chem. 1979 Feb;22(2):134-50. doi: 10.1021/jm00188a005.
2
Potential antitumor agents. 31. Quantitative structure-activity relationships for the antileukemic bis(guanylhydrazones).
J Med Chem. 1979 Oct;22(10):1234-8. doi: 10.1021/jm00196a016.
3
Potential antitumor agents. 21. Dialkanolamine dialkanesulfonic esters.
J Med Chem. 1977 Apr;20(4):515-20. doi: 10.1021/jm00214a011.
4
Potential antitumor agents. 33. Quantitative structure--activity relationships for mutagenic activity and antitumor activity of substituted 4'-(9-acridinylamino)methanesulfonanilide derivatives.
J Med Chem. 1980 Mar;23(3):269-74. doi: 10.1021/jm00177a011.
5
Potential antitumor agents. 35. Quantitative relationships between antitumor (L1210) potency and DNA binding for 4'-(9-acridinylamino)methanesulfon-m-anisidide analogues.潜在的抗肿瘤药物。35. 4'-(9-吖啶基氨基)甲磺酰基间茴香胺类似物的抗肿瘤(L1210)效力与DNA结合之间的定量关系。
J Med Chem. 1981 May;24(5):520-5. doi: 10.1021/jm00137a009.
6
Potential antitumor agents. 27. Quantitative structure--antileukemic (L1210) activity relationships for the omega-[4-(9-acridinylamino)phenyl]alkanoic acids.
J Med Chem. 1978 May;21(5):430-7. doi: 10.1021/jm00203a005.
7
Potential antitumor agents. 18. Bisquaternary ammonium heterocycles.潜在的抗肿瘤药物。18. 双季铵杂环化合物。
J Med Chem. 1976 Dec;19(12):1417-9. doi: 10.1021/jm00234a013.
8
ICRF-187 rescue in etoposide treatment in vivo. A model targeting high-dose topoisomerase II poisons to CNS tumors.ICRF - 187对依托泊苷体内治疗的挽救作用。一种将高剂量拓扑异构酶II毒药靶向中枢神经系统肿瘤的模型。
Cancer Chemother Pharmacol. 1996;38(3):203-9. doi: 10.1007/s002800050472.
9
Potential antitumor agents. 42. Structure-activity relationships for acridine-substituted dimethyl phosphoramidate derivatives of 9-anilinoacridine.
J Med Chem. 1984 Aug;27(8):1053-6. doi: 10.1021/jm00374a020.
10
[Quenching of ethidium-DNA fluorescence by novel acridines with antitumor activities].[新型具有抗肿瘤活性的吖啶对溴化乙锭 - DNA荧光的猝灭作用]
Yakugaku Zasshi. 1992 Dec;112(12):914-8. doi: 10.1248/yakushi1947.112.12_914.

引用本文的文献

1
Metabolic reprogramming and epigenetic modifications on the path to cancer.癌症发生过程中的代谢重编程和表观遗传修饰。
Protein Cell. 2022 Dec;13(12):877-919. doi: 10.1007/s13238-021-00846-7. Epub 2021 May 29.
2
A new class of quinoline-based DNA hypomethylating agents reactivates tumor suppressor genes by blocking DNA methyltransferase 1 activity and inducing its degradation.一类新型的基于喹啉的DNA去甲基化剂通过阻断DNA甲基转移酶1的活性并诱导其降解来重新激活肿瘤抑制基因。
Cancer Res. 2009 May 15;69(10):4277-85. doi: 10.1158/0008-5472.CAN-08-3669. Epub 2009 May 5.
3
Minor groove binding of a bis-quaternary ammonium compound: the crystal structure of SN 7167 bound to d(CGCGAATTCGCG)2.
一种双季铵化合物的小沟结合:与d(CGCGAATTCGCG)2结合的SN 7167的晶体结构
Nucleic Acids Res. 1997 Oct 15;25(20):4072-8. doi: 10.1093/nar/25.20.4072.
4
DNA-binding characterization of a novel anti-tumour benzo[a]phenazine derivative NC-182: spectroscopic and viscometric studies.新型抗肿瘤苯并[a]吩嗪衍生物NC-182的DNA结合特性:光谱学和粘度测定研究
Biochem J. 1994 Nov 15;304 ( Pt 1)(Pt 1):271-9. doi: 10.1042/bj3040271.
5
Nonintercalative DNA-binding antitumour compounds.非嵌入性DNA结合抗肿瘤化合物。
Mol Cell Biochem. 1982 Apr 2;43(3):167-81. doi: 10.1007/BF00223008.